Cipla said that the ‘Mother-Baby Pack’ has been developed in line with the latest World Health Organisation (WHO) guidelines on Prevention of Mother-to-Child Transmission (PMTCT) Option A .
The Mother-Baby Pack is a color-coded take-home kit with simple graphics to help mothers identify the different sets of drugs each to be taken during pregnancy, during labour and breastfeeding, covering the entire period when the transmission can occur.
The drugs for the Mother-Baby Pack are being manufactured and packaged in Cipla’s manufacturing units in Goa and Patalganga which are approved by WHO-Geneva, USFDA, MHRA-UK and various other regulatory bodies.
Cipla chairman and managing director YK Hamied said they were approached by UNICEF to produce this pack for the PMTCT program.